Hyperfine Announces Completion Of Enrollment In Contrast PMR Study Of Swoop Portable MRI; Plans FDA 510(k) Submission By End Of 2026 For First Indication Expansion

Loading news article.

Hyperfine Announces Completion Of Enrollment In Contrast PMR Study Of Swoop Portable MRI; Plans FDA 510(k) Submission By End Of 2026 For First Indication Expansion | WAPE

Hyperfine Announces Completion Of Enrollment In Contrast PMR Study Of Swoop Portable MRI; Plans FDA 510(k) Submission By End Of 2026 For First Indication Expansion

Article summary

Related companies

Comments —